Similar articles

• [Immunomodulatory therapy in multiple sclerosis].

  Csépány T, Bereczki D. Csépány T, et al. Ideggyogy Sz. 2004 Nov 20;57(11-12):401-16. Ideggyogy Sz. 2004. PMID: 15662768 Review. Hungarian.
• Intensive immunosuppression in multiple sclerosis.

  Zaffaroni M, Ghezzi A, Comi G. Zaffaroni M, et al. Neurol Sci. 2006 Mar;27 Suppl 1:S13-7. doi: 10.1007/s10072-006-0539-5. Neurol Sci. 2006. PMID: 16708175 Review.
• [Multiple sclerosis--recent advances in pathogenesis and treatment].

  Itoyama Y, Fujihara K, Nakashima I, Misu T, Fujimori T, Sato S. Itoyama Y, et al. No To Shinkei. 2002 Jan;54(1):5-21. No To Shinkei. 2002. PMID: 11868352 Review. Japanese. No abstract available.
• Immunoadsorption (IA) versus plasma exchange (PE) in multiple sclerosis--first results of a double blind controlled trial.

  Schmitt E, Behm E, Buddenhagen F, Ernst B, Hitzschke B, Kracht M, Korten G, Kundt G, Meyer-Rienecker H, Osten B, et al. Schmitt E, et al. Prog Clin Biol Res. 1990;337:289-92. Prog Clin Biol Res. 1990. PMID: 2191322 Clinical Trial. No abstract available.
• Landmark papers in multiple sclerosis.

  Cross AH. Cross AH. Neurology. 2001 Dec;57(12 Suppl 5):S1-2. Neurology. 2001. PMID: 11902588 No abstract available.